Year archive

Immunotech Biopharm Ltd — 2024 filings

All 34 regulatory filings released by Immunotech Biopharm Ltd (6978) in 2024, sourced directly from the official regulator.

34 Filings

2024 Period

2024 filings (34)

Filing	Released	Lang
UPDATE ON THE CONVERTIBLE BONDS ISSUED UNDER SPECIFIC MANDATE Capital/Financing Update	2024-12-31	English
VOLUNTARY ANNOUNCEMENT CAR-T-19 INJECTION WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION Regulatory Filings	2024-12-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-05	English
RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE Board/Management Information	2024-12-02	English
UPDATE ON CONTRACTUAL ARRANGEMENTS Regulatory Filings	2024-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-07	English
2024 INTERIM REPORT Regulatory Filings	2024-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-04	English
ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Regulatory Filings	2024-08-23	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-05	English
RESIGNATION OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE AND APPOINTMENT OF JOINT COMPANY SECRETARIES AND AUTHORISED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WIT Regulatory Filings	2024-07-26	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-03	English
DISCLOSEABLE TRANSACTION DISPOSAL OF THE CERTIFICATES OF DEPOSITS Regulatory Filings	2024-06-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 24 MAY 2024 Regulatory Filings	2024-05-24	English
FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2024-05-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 24 MAY 2024 Regulatory Filings	2024-04-29	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-04-29	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND Regulatory Filings	2024-04-29	English
2023 ANNUAL REPORT Regulatory Filings	2024-04-29	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-03	English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2024-03-28	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 Regulatory Filings	2024-03-28	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-05	English
VOLUNTARY ANNOUNCEMENT THE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION Regulatory Filings	2024-02-19	English
Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-05	English
Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-02	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIAL FOR CAR-T-19 INJECTION Regulatory Filings	2024-01-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-03	English